Edward Kim, MD: Abraxane for lung cancer
Edward S Kim, MD, Chief, section of head and neck medical oncology, at The MD Anderson Cancer Center discusses the albumin-bound paclitaxel drug branded as Abraxane to treat NSCLC. He reviews the recent phase 3 trial and the possibility that the drug might work in squamous cell variety whereas many other lung cancer drugs are ineffective in squamous cell cancers of the lung
MD Anderson, Oncology | apples49 | 
February 15, 2011 12:32 pm
No Comments
No comments yet.
Notice: comments_rss_link is deprecated since version 2.5! Use post_comments_feed_link() instead. in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3406
RSS feed for comments on this post.
TrackBack URI
